您的位置: 首页 > 农业专利 > 详情页

Korean medicine material composition for treating Chemotherapy-induced peripheral neuropathy
专利权人:
DAEJEON UNIVERSITY INDUSTRY-UNIVERSITY COOPERATION FOUNDATION
发明人:
JO, CHUNG SIK,조충식,NAM, GUNG WOOK,남궁욱,AN, SO HYUN,안소현
申请号:
KR1020170104156
公开号:
KR1019328560000B1
申请日:
2017.08.17
申请国别(地区):
KR
年份:
2018
代理人:
摘要:
The present invention relates to a medicinal herb composition for treatment of anticancer drug-induced peripheral neuropathy, and more specifically, to a medicinal herb composition for treatment of anticancer drug-induced peripheral neuropathy without side effects. The present invention provides the medicinal herb composition for the treatment of the peripheral neuropathy caused by the anticancer drugs extracted by mixing ginseng, Paeonia lactiflora, Ostrea gigas and Angelica gigas. In addition, the present invention also provides the medicinal herb composition for treatment of anticancer drug-induced peripheral neuropathy, which is obtained by mixing and extracting 150 to 230 parts by weight of the Paeonia lactiflora, 180 to 250 parts by weight of the Ostrea gigas and 150 to 230 parts by weight of the Angelica gigas with 100 parts by weight of the ginseng. The present invention also provides a pharmaceutical composition comprising the medicinal composition for treatment of the anticancer drug-induced peripheral neuropathy.본 발명은 항암제 유발 말초신경병증 치료를 위한 한약재 조성물로서, 더욱 구체적으로는 부작용 없이 항암제 유발 말초신경병증 치료를 할 수 있는 한약재 조성물에 관한 것이다.본 발명은 인삼, 작약, 모려, 당귀를 혼합하여 추출한 항암제 유발 말초신경병증 치료를 위한 한약재 조성물을 제공한다.또한 본 발명은 인삼 100중량부에 작약 150~230중량부, 모려 180~250 중량부, 당귀 150~230 중량부를 혼합하고 추출한 것을 특징으로 하는 항암제 유발 말초신경병증 치료를 위한 한약재 조성물을 제공한다.또한 본 발명은 항암제 유발 말초신경병증 치료를 위한 한약재 조성물을 포함하는 약제학적 조성물을 제공한다.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充